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cAMP-regulated trafficking of epitope-tagged CFFR. The cystic fibrosis
transmembrane conductance regulator (CFTR) is a phosphorylation-
activated chloride channel responsible for cAMP-induced Cl secretion
across the apical membranes of epithelial cells. To optimize its detection
in membrane localization studies, we tagged CFTR with epitope se-
quences at the carboxy terminus or in the fourth external loop. The
function of six different tagged-CFTRs was tested in two different
physiological assays. CFTRs containing the M2 epitope responded to
cAMP, whereas cells expressing CFTR with the hemagglutinin I-LA tag
showed little or no cAMP response. Using CFTR tagged in the fourth
external ioop, we demonstrate that cAMP activation using forskolin
results in an increase in CFTR in the plasma membrane of HeLa cells.
Forskolin inhibited CFTR endocytosis, and this contributes to the increase
in cell surface CFTR expression. Our results indicate that regulation of
cell surface CVFR contributes to the increase in plasma membrane Cl
conductance evoked by cAMP stimulation.
Cystic fibrosis transmembrane conductance regulator (CFTR)
is involved in the cAMP-dependent regulation of membrane
trafficking. Epithelia that express wild-type (wt) CFI'R show
cAMP-induced activation of exocytosis and inhibition of endocy-
tosis [1]. These cAMP-induced changes in membrane recycling
cause a proliferation of membrane surface area detected as an
increase in membrane capacitance measurements [2]. Cystic
fibrosis (CF) cells lack the cAMP-dependent regulation of these
membrane trafficking events, which can be restored by expression
of wt CFTR in CF cells [1]. Prince and Marchase [3] used a
surface labeling strategy to measure directly the effect of cAMP-
activation on CFTR endocytosis. Forskolin inhibited endocytosis
of 50% of plasma membrane CFTR in T84 cells, detected from
immunoprecipitation of the surface-labeled protein.
cAMP-regulation of membrane trafficking events could contrib-
ute to the expression of active CFTR Cl channels in the apical
membranes of secretory epithelial cells, providing an ancillary
means of increasing apical Cl conductance, in addition to the
direct activation of membrane-resident CFTR. Of critical impor-
tance is the question of whether CFTR itself is a passenger in this
cAMP-regulated apical membrane traffic or whether it regulates
these events from another location. If it is the former, then it
becomes important to define the membrane turnover properties
of various CFTR mutants. Their residency in the plasma mem-
brane may correlate with impairments described for regulation of
their Cl conductance, and this would support the idea that
conduction and trafficking are causally related. Moreover, en-
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hancing the plasma membrane residence time of mutant CFTRs
may provide a means of enhancing apical Cl conductance.
Our understanding of wild-type (wt) and mutant CFTR local-
ization, trafficking and membrane insertion is incomplete. These
issues could be addressed at greater resolution with more sensitive
CFTR detection assays. We chose to epitope-tag the CFTR
protein on one of the external loops and at the C-terminus as a
means to detect the protein when it is expressed in various cell
lines and tissues. The advantage of this approach is the use of a
small highly hydrophillic epitope, engineered into the protein at a
specific site, and the availability of a specific monoclonal antibody
that can be used to detect the epitope. This results in increased
sensitivity and specificity of protein detection. Epitope-tagging has
been used successfully with a variety of proteins to determine their
cellular locations [4], subcellular targeting [5] and protein-protein
interactions [6].
In this paper, we briefly review the procedures used for tagging
and functional analysis of six CFTR constructs, tagged with two
different epitopes [7]. Using one of these constructs, we demon-
strate that cAMP-activation results in (1) an increase in the
number of CFTR molecules in the plasma membrane under
steady-state conditions and (2) inhibition of CFTR endocytosis.
Methods
Virus, plasmid and cells
Recombinant vaccinia virus expressing the T7 bacteriophage
RNA polymerase (vTF7-3) and the pTM1 plasmid were provided
by Dr. B. Moss of the National Institutes of Health [8]. Stocks of
vTF7-3 were prepared in HeLa cells, and infectivity titers were
determined by plaque assay on HeLa cells. HeLa cells were
maintained as monolayer cultures in Delbecco's minimal essential
medium (DMEM) containing 10% heat-inactivated calf serum.
Epitope-tagged CFTR constructs
Epitope tags were introduced into the CFTR coding sequence
using a PCR-based technique, an approach that resulted in 50 to
70% of clones positive for insertion of the epitope tag (data not
shown). Sequences encoding either the Influenza hemagglutinin
(HA) epitope, YPYDVPDYA, [9] or the M2 epitope, DYKD-
DDDK (Kodak) were inserted in frame with the coding sequence
of CFTR after nucleotide positions 2820 (HA and M2 epitopes),
2835 (M2 epitope) or 4572 (HA and M2 epitopes). The corre-
sponding M2 or HA-tagged CFTRs are designated by the site of
epitope addition (that is, the amino acid immediately preceding
the epitope sequence). The protocol was performed as described
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Table 1. SPQ analysis of tagged CVFR proteins expressed in HeLa cells
wt M2-901/dg M2-901 wt/dg M2-C vv
Control 1.5 0.1 1.8 0.1 0.81 0.1 1.2 0.1 1.6 0.2 1.2 0.1
cAMP 5.9 0.6° 9.5 1.1° 7.9 0.98° 8.6 1.la 5.6 1.oa 1.0 0.1
The values represent the slopes associated with dequenching of SPQ fluorescence in nitrate media in the presence (cAMP) and absence (control) of
400 M cpt-cAMP, 5 M forskolin and 100 tLM IBMX.
°P <0.0001
by Howard et al [7]. Site-directed mutagenesis was carried out
using the method of Deng and Nickoloff [10].
RNA synthesis
Epitope-tagged CFTR constructs (pBluescript vector) were
linearized and RNA was synthesized from the DNA templates
using the RibomaxTM kit (Promega) and the bacteriophage T7
RNA polymerase as described by Howard et a! [7]. Each prepa-
ration of RNA was analyzed by denaturing gel electrophoresis for
full-length CFTR RNA.
Expression of CFTR using the vaccinia/T7 system
HeLa cells were plated on collagen-coated coverslips in 35 mm
dishes at a density of 5 X io. Cells were infected with vTF7-3 at
a multiplicity of infection (MOl) of 7. Following adsorption, the
monolayers were washed twice in serum-free media and trans-
fected with pTM1CFTR (± tag sequences) using lipofectin
(BRL) at a concentration of 10 .tg/ml according to the manufac-
turer's procedures. Following five hours of incubation, the mono-
layers were washed twice with DMEM containing 10% calf serum
and incubated in media containing serum prior to analysis.
Expression of CFTR using Xenopus laevis oocytes
Isolation of oocytes and injection of CFTR RNA were per-
formed as described previously [11]. Oocytes were injected with
50 ng of RNA for either wt CFTR or tag CFTR in 50 nI water, or
with water alone. Membrane currents were evaluated two days
after injection by double-electrode voltage clamp as described
[11]. Current-voltage relations were determined before and 15 to
25 minutes after perfusion with a cAMP cocktail consisting of 10
.LM forskolin and 1 mvi 3-isobutyl-1-methylxanthine (IBMX). To
determine whether current responses following cAMP cocktail
perfusion were significantly different from baseline, paired t-tests
were performed to compare the membrane conductances (slope
of the I-V relationship) before and after cAMP treatment.
SPQ fluorescence microscopy
HeLa cells infected with vTF7-3 and transfected with plasmid
DNA were monitored for plasma membrane Cl permeability by
measuring the fluorescence dequenching of the halide-sensitive
fluorophore, SPQ (Molecular Probes) as described [12]. The cells
were exposed to 400 M cpt-cAMP, 5 iM forskolin, and 100 j.LM
IBMX to determine the effect of increasing cellular cAMP on
halide permeability during bath anion substitution. In cells ex-
pressing wt CFTR, this cocktail has been shown previously to
produce a maximal rate of SPQ fluorescence dequenching in
response to cAMP in cells expressing wt CFTR [12].
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Fig. 1. Schematic of CFTR protein. Letters represent single amino acid
code. Arrows represent place of insertion of the epitope tag.
Immunofluorescence
Cell suiface CFTR under steady-state conditions. For cell surface
staining, HeLa cells were infected with vTF7-3 and transfected
with plasmid DNA as described above. At eight hours post-
infection, cells were incubated with culture media with or without
10 jiM forskolin for ten minutes at 37°C. The media were then
removed and the cells rapidly cooled to 4°C by washing twice with
ice cold PBS. Then they were incubated in 50 jsl of M2 antibody
(7 jig/mI, Kodak) for 15 minutes at 4°C. The coverslips were again
washed twice in PBS and incubated in 50 jil of a 1:10 dilution of
a fluorescein-conjugated goat anti-mouse antibody (Boehringer
Mannheim, Mannheim, Germany) for 15 minutes at 20°C. The
coverslips were washed twice in PBS, the cells were then fixed by
incubation in 1% formalin for 15 minutes at 20°C and mounted on
glass slides in 0.1% paraphenyldiamine, 90% glycerol, 0.1 M PBS,
pH 7.4.
Quantitation of cell surface fluorescence was performed by
collecting images with a cooled CCD camera mounted on a Zeiss
IM-35 microscope equipped with a l6XPlan-Neofluar objective
and appropriate filter sets to separate the fluorescence of FITC
from that of the nuclear stain, Hoescht 33342. Images of five
-COOH
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Table 2. Whole-cell chloride conductance from Xenopus oocytes injected with 50 ng in vitro transcribed mRNA
Water M2-C wtCFTR M2-901° wtCFTR*
Control 3.7 0.55 1.77 0.44 4.11 0.61 2.65 0.44 3.38 1.25
cAMP 4.29 0.83 63.44 15.8° 60.47 17.6 18.63 654b 31.65 7.94
Values represent the slopes associated with the whole cell conductance (nS) before cAMP stimulation (control) and after stimulation with cAMP (10
j.LM forskolin and 1 ma 3-isobutyl-1-methylxanthine, IBMX). Compare M2-901° and wtCFTR* which were assayed on the same day in a separate
experiment from the other constructs.
°P < 0.05; bP < 0.05
randomly selected fields were collected, relayed to a Macintosh
computer and analyzed as follows. A threshold fluorescence
intensity value differentiating between fluorescently stained and
unstained cells was determined based on the intensity profiles of
unstained cells. The criteria for determining the threshold was
that less than 5% of autofluorescence may fall above the thresh-
old. The same threshold was applied to all images taken and
intensity values above the threshold were integrated for each set
of five images for a given preparation. The number of cell nuclei
of each field was determined based on the staining of DNA with
Hoescht 33342. The integrated FITC fluorescence of each set of
images was normalized to the number of nuclei observed on the
corresponding Hoescht images to obtain relative cell fluorescence.
Endocytosis
vTF7-3 infected HeLa cells expressing M2-901!dgCFTR were
incubated in the presence or absence of forskolin for 30 minutes
at 37°C and then stained with M2 antibody at 4°C for 15 minutes.
The cells were either stained immediately with FITC-labeled
secondaiy antibody at 4°C (zero time point) or warmed to 37°C
for one, two or five minutes in the presence or absence of
forskolin prior to secondary antibody staining. Other procedures
were as described above.
Results
The criteria to be met in tagging CFTR were to produce a
protein that: (i) was readily detectable by immunofluorescence
using a commercially available antibody; (ii) could be detected at
the surface of non-permeabilized cells; and (iii) would demon-
strate a cAMP-inducible chloride current. It was essential that
tagged CFTR perform as a cAMP-activated Cl conductance in
various physiological assays (discussed below). Therefore, the
proposed physical structure of the protein was considered with
regards to placement of the epitope.
As discussed previously [71, the 1480 amino acid CFTR protein
is predicted to have twelve membrane spanning domains, with
only 4% of the protein sequence external to the plasma mem-
brane [13]. Both the amino and carboxy termini of the protein are
predicted to be intracellular. The overall amino acid homology
among CFTRs of different species is greater than 70% identity
and 85% similarity. Other proteins have been shown to retain
function when epitope tags are fused to their carboxy terminus
[14], and therefore we tagged CFTR at this site. We also tagged
CFTR at two different locations in the fourth extracellular loop. A
tag on an extracellular loop would allow immunofluorescent
localization of CFTR in the plasma membrane without fixation or
permeabilization.
Briefly, the rationale for tagging CFTR at the fourth extracel-
lular loop was as follows. Of the amino acids predicted to be
extracellular, the fourth loop is the largest. This loop shows
structural divergence among species (51% homology), as com-
pared to 93% similarity for the first external loop, 94% similarity
for the first nucleotide binding domain and 85% overall similarity
for the CFTR protein. We reasoned that the fourth ioop might
tolerate addition of amino acids without disruption of function.
However, the fourth extracellular loop contains two asparagines
(amino acids 894 and 900) that are glycosylated [15], and this
glycosylation is substantial, resulting in an apparent shift in
molecular weight of 15,000 to 30,000 daltons. To determine
whether CFTR glycosylation would interfere with its detection by
antibody, we evaluated the influence of mutagenizing the aspar-
agines to glutamines on CFTR function and immunofluorescence.
Prior studies [151 suggested that function was preserved by this
procedure, but the assay employed (SPQ fluorescence) is rela-
tively insensitive from a quantitative viewpoint. Our results repro-
duced these findings. When the M2 epitope was added to either
deglycosylated (dg) or wt CFTR, the cAMP stimulatory cocktail
increased SPQ fluorescence in a manner similar to that observed
for wt CFTR. There were no apparent differences in stimulation
of wt and dg CFTR and these proteins were functional whether
the tags were added after amino acid 901 (4th extracellular loop)
or at the C-terminus. However, tag constructs utilizing the hem-
agglutinin epitope were not functional in this assay (see Howard
et al [7]).
Tagged CFTR function was analyzed with greater sensitivity by
injecting Xenopus oocytes with RNAs obtained from the tag
constructs (Table 2) [7]. As with SPQ, the wild-type and M2-
tagged constructs generated a whole-cell Cl conductance response
to cAMP. However, in this assay, the deglycosylated CFTRs (both
tagged and untagged) showed conductance responses that were
only 20% of the response of wt CFTR with the glycosylation sites
intact (data not shown) [71. These results show that it is the
absence of CFTR glycosylation and not the addition of the
epitope tag that results in the reduced whole-cell CI conductance
response of dgCFTRs. M2-C/CFTR retains the glycosylation sites
and yields a whole-cell conductance comparable to wild-type
CFTR (Table 2). The SPQ assay did not detect these glycosyla-
tion-associated differences in CFTR function, presumably due to
its lower sensitivity.
The M2-901/CFTR functioned like wild-type CFTR and was
readily detected at the cell surface in live, rion-permeabilized cells
(see below and [7]). To further analyze the effect of the tag on
function and trafficking of CFTR, five mutations were produced in
combination with this tagged construct, and their function and
surface expression were analyzed. The five mutations studied
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Table 3. SPQ analysis of tagged mutant CFTR proteins
SF508 G551D K1250M N1303K G1349D
Control 0.95 0.14 1.06 0.09 1.22 0.08 1.33 0.20 0.84 0.18
cAMP 1.17 0.16 1.15 0.11 8.73 0.86a 1.59 0.24 2.98 0.36°
The values represent the slopes associated with dequenching of SPO fluorescence in nitrate media in the presence (cAMP) and absence (control) of
400 I.LM cpt-cAMP, 5M forskolin and 100 rM IBMX.
ap
were: SF508, GS51D, K1250M, N1303K, and G1349D. These
mutations have been previously characterized for their processing
to form glycosylated proteins (that is, the molecular weight shift
associated with carbohydrate addition to form a "C band,"
suggesting transit through the Golgi). They were also analyzed for
function, using the SPQ assay. As shown in Table 3, the M21
K1250M and M2/G1349D mutants showed significant responses
to cAMP stimulation in the SPQ assay when expressed in HeLa
cells. The M2/F5O8, M2/G551D, and M2/N1303K mutants did
not show significant cAMP-induced changes in Cl permeability.
These findings are in agreement with the previously published
functional analyses of these CFTR mutants [15]. The results
suggest that addition of the M2 epitope after amino acid 901 does
not alter the pattern of processing and functional expression of
these structural CFTR variants.
The mutants G551D, K1250M, and G1349D have been shown
previously to be processed to glycosylated proteins; they are
therefore thought to traffic to the cell surface. iF508 and N1303K
are not glycosylated and thus are not expected to be expressed in
the plasma membrane. The cell surface expression of these
mutants was determined in HeLa cells after vaccinialT7 expres-
sion by immunofluorescence [7]. M2/F5O8 and M2/N1303K were
not detected at the cell surface by immunofluorescence, whereas
the other three M2/CFTR mutants (G551D, K1250M and
G1349D) showed cell surface expression. Thus, these results also
correlate with the biochemical data regarding mutant CFTR
processing (formation of the C band) [15].
The development of an extracellular epitope-tagged CFTR
construct that both traffics and functions like wild-type CFTR
enables us to study the cell biology of this protein in greater detail.
Results from previously published studies suggest that CFTR
confers cAMP-regulated plasma membrane recycling (endocyto-
sis and exocytosis) in a manner that would be expected to increase
the amount of plasma membrane CFTR when cells are stimulated
by cAMP, and this would provide one means of increasing their Cl
conductance [11. This proposal was tested directly by assessing cell
surface expression of M2-901/CFTR in HeLa cells in the presence
and absence of cAMP. Live, non-permeabilized cells were incu-
bated in media in the absence or presence of 10 jIM forskolin for
ten minutes prior to staining with FITC-labeled secondary anti-
body at 4°C. After staining, the cells were fixed and mounted for
microscopic examination and quantitation. Table 4 shows the
fluorescence intensity from three independent experiments of this
type. As a control, the same assays were performed in HeLa cells
expressing vesicular stomatitis virus (VSV) glycoprotein G using
methods identical to those for CFTR. There is no evidence to
indicate that VSV-G protein undergoes cAMP-regulated mem-
brane trafficking, and these studies did not show a change in cell
Table 4. Quantitation of cell surface fluorescence intensity of HeLa
cells expressing M2-901/CFTR in the absence or presence of 10 javt
forskolin
Experiment 1 Experiment 2 Experiment 3
(—) Forskolin 11,497 (354) 13,335 (210) 13,737 (378)
(+) Forskolin 33,217 (366) 27,212 (187) 19,810 (307)
Number in parentheses are number of cells assayed in each experiment.
Quantitation was determined as outlined in the Methods section.
surface VSV-G protein labeling upon forskolin stimulation (data
now shown).
Similar experiments were carried Out using an MDCK cell-line
that is stably transfected with the pMEP4 vector subcloned with
M2-901/CFTR. In this construct, M2-901/CFTR is expressed from
the inducible metallothionein promoter. Preliminary data show
that after 20 minutes exposure to 10 JIM forskolin at 37°C, a
twofold increase in cell surface fluorescence was detected using
the M2 antibody (data not shown).
These results indicate that forskolin stimulates steady-state
expression of M2-901/CFTR at the cell surface. This increase in
plasma membrane CFTR could result from an inhibition of CFTR
endocytosis, a stimulation of CFTR exocytosis or both. Results
obtained prior to the availability of the M2-901/CFTR construct
address this issue. Experiments were performed to study the effect
of cAMP on the endocytosis of the M2-901 tagged CFTR. vTF7-3
infected HeLa cells expressing M2-901/dgCFTR were incubated
in the presence or absence of forskolin for 30 minutes at 37°C and
then stained with M2 antibody at 4°C for 15 minutes. The cells
were either stained immediately with FITC-Iabeled secondary
antibody at 4°C (zero time point) or warmed to 37°C for one, two
or five minutes in the presence or absence of forskolin prior to
secondary antibody staining. As shown in Figure 2, most of the
M2/CFTR was endocytosed from the cell surface within two
minutes of warming at 37°C. However, in the presence of forsko-
lin, CFTR endocytosis was significantly inhibited.
The rapid endocytosis of M2/CFTR and its inhibition by
forskolin is in sharp contrast to the lack of endocytosis of the
VSV-G protein under similar conditions (data not shown). There
is no evidence to suggest that VSV-G protein undergoes plasma
membrane recycling. Its surface expression did not change during
five minutes incubation at 37°C in the presence or absence of
forskolin. This provides further evidence that CFT'R endocytosis
is not evoked non-specifically by the experimental conditions
employed (such as induced by antibody binding). Quantitation of
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Fig. 2. The effect of forskolin on M2-9O1Id8CFTR endocytosis. Cell surface CFTR at zero-time (A, B) or two minutes. (C, D) after rewarming to 37°C
in the absence (A,C) or presence (B,D) of 10 /LM forskolin.
these experiments can yield a rate coefficient for CFTR endocy-
tosis that can be compared among different experimental condi-
tions (stimulation) and between different CFTR mutants.
Discussion
This study was undertaken to access the cellular location of
CFTR when it is expressed in the plasma membrane domain as an
epitope-tagged protein. This required the insertion of an epitope
within an extracellular loop of CFTR. Most epitope tagging
studies have added epitope sequences to either the C-terminus or
N-terminus of expressed proteins. Of critical importance in estab-
lishing this as a useful technique for CFTR localization was
retention of CFTR function. Adding charged amino acid se-
quences to an internal site raises the possibility of disrupting
tertiary structure and impairing the cAMP-regulated Cl channel
function of the protein. This could result from an impairment in
channel conductance, gating or regulation, or from disruption of
its cellular trafficking properties. Indeed, in prior studies we found
that certain epitope sequences interfere with the ability of tagged
CFTRs to traffic to the plasma membrane domain [7].
The utility of the extracellular epitope tag is demonstrated by
our studies of the regulation of cell surface expression of CFTR.
The adequacy of the M2-901/CFTR construct in this respect is
shown by its plasma membrane distribution. In addition, its
function as a cAMP stimulated Cl conductance is not different
from wild type CFTR, as assessed in two functional assays. The
function of M2-901/CFTR as a regulated chloride conductance
was demonstrated utilizing both fluorescence and Cl conductance
assays. In HeLa cells transiently expressing the tagged construct,
increases in fluorescence upon cAMP stimulation were not dif-
ferent from those observed with wild type CFTR. In addition,
when this construct was expressed in Xenopus oocytes, the chlo-
ride conductance increase observed on stimulation by cAMP
agonists was also similar to the observed for wild-type CFTR.
Other studies not reported here have suggested that the single
channel properties of M2-901!CFTR are also indistinguishable
from wt CFTR.
We performed a number of studies to determine whether
carbohydrate addition to the fourth extracellular loop would
interfere with the ability of M2 antibodies to stain the surface of
non-permeabilized cells. Our fear was that steric hindrance pro-
duced by the addition of carbohydrate at these sites would prevent
antibody binding. In anticipation of this problem, we produced a
deglycosylated version of the M2-CFTR construct (dg CFTR), but
the experimental results showed these concerns were unfounded.
In fact, the deglycosylated CFTR yielded a lower level of Cl
conductance stimulation regardless of whether it contained the
tag sequence. The mechanism whereby deglycosylation compro-
mises the cAMP-dependent CI conductance is under further
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study, and may involve changes in its plasma membrane expres-
sion. Nevertheless, we identified a site for insertion of the tag
sequence, following amino acid 901, that yielded a fully functional
tagged protein. This M2-901 construct appears to be optimal for
the detection of cell surface CFTR and for further analysis of its
regulation.
Assessment of several M2-tagged CFTR mutants confirmed its
utility. The expression of a number of disease mutations with the
M2-901 tag showed that their cell surface expression correlated
with their ability to undergo carbohydrate addition, a measure of
whether they traffic through the protein secretory pathway. Par-
ticularly interesting in this respect were the SF508 and G551D tag
constructs; both of these mutations produce severe CF. They
exemplify differences in the way CFTR mutants are processed by
cells, and differences in the molecular mechanisms whereby the
defect in cAMP-stimulated Cl conductance is produced. In the
case of SF508 CFTR, the lack of cell surface expression corre-
lated with the absence of carbohydrate processing. In the case of
G551D CFTR, a glycosylated protein is produced. Previous
studies using permeabilized cells have suggested that this protein
co-localizes with the Na,K-ATPase and is thus plasma membrane
associated [12J. However, at the level of resolution provided by
indirect immunofluorescence, we could not rule out the possibility
that the G551D protein was present at a submembrane site. The
external epitope tag clearly shows that G551D CFTR resides
within the plasma membrane. Thus, the defect in cAMP-stimu-
lated Cl conductance of G551D CFTR arises from alterations in
its ATP-dependent gating and not from defects in its cellular
location. The correlation of surface expression with the glycosyl-
ation patterns of various mutants confirms the utility of the
M2-901 tag for further studies of the cell biology of mutant CFTR
proteins.
An extracellular CFTR tag permits direct assessment of the role
of CFTR in acute regulation of membrane trafficking and whether
there is cAMP-dependent exocytosis and endocytosis of CFTR
itself. The results from the trafficking assays using the M2-901
construct indicate that CFTR participates in this process. Steady-
state labeling by the M2 antibody showed a two- to threefold
increase in cell surface CFTR on stimulation by forskolin. The
timing of the assay (5 to 10 mm stimulation) correlates with the
time for maximal stimulation of Cl conductance in whole-cell
patch clamp recordings or for transepithelial Cl secretion across
epithelial monolayers. Thus, these results indicate that insertion
of CFTR into the plasma membrane is one mechanism whereby
stimulation of protein kinase A leads to an increase in apical
membrane Cl conductance.
Finally, M2-901 CFTR was utilized to assess the effect of cAMP
on CFTR endocytosis. Prince and Marchase [3] found a 50%
decrease in the rate of internalization of surface CFTR when T84
cells were stimulated with cAMP-dependent agonists. Although
they have not been quantitated, our studies support these findings
and indicate that a decrease in CFTR endocytosis is one mecha-
nism whereby cAMP stimulation enhances its cell surface expres-
sion during steady-state stimulation of Cl secretion. One caveat is
whether the de novo proteins synthesized by vaccinia virus, used as
the expression vector in these experiments, could contribute to the
cAMP effect seen with CFTR. To answer that question, a
polarized, stable cell line expressing CFTR was developed. Pre-
liminary data using this cell line shows the same cAMP effect on
CFFR as that seen in HeLa cells.
The epitope tagged CFTR should be useful for a variety of cell
biological studies in which high resolution detection of cellular
location of this protein is desirable. Antibodies raised to various
domains of CFTR have lacked the necessary sensitivity to detect
low levels of protein expression. The added antigenic epitope is
distinct from endogenous peptide sequences, and provides for a
low background. This is particularly true for the CFTR construct
tagged at an extracellular locus since cell permeabilization is not
required in the assay. Finally, the use of an epitope-tagged CFTR
can provide for its experimental detection during exogenous
expression, such as in gene transfer experiments, where it may be
necessary to identify the protein in a background of endogenous
wt CFTR.
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